MaxCyte’s flow electroporation is driving the next generation of cell-based medicines. Used in the discovery, development, and manufacture of cell-based therapeutics, the MaxCyte GT® Flow Transfection System, MaxCyte STX® Scalable Transfection System, and MaxCyte VLX® Large Scale Transfection System enable the development of transfected cells for a range of applications.
Miltenyi Biotec’s mission is to improve scientific understanding and medical progress. By developing innovative products that address the processes that are necessary for the study of immuno-oncology we help researchers advance science in these key areas as well as help clinicians to make the concept of cellular therapy a reality.
Promab Biotechnologies provides a completely comprehensive CAR-T pre-clinical package, allowing for accelerated proof-of-concept, and IP positioning, beginning with the generation of a mouse, rabbit, or human (library) monoclonal antibody, or with the synthesis and cloning of existing antibody sequence into a CAR expression construct. Promab is positioned to explore collaboration with partners in order to rapidly expand clinical targets. Read more here.
For over 36 years, Quick has been safely transporting human organs, tissue, blood and blood products, personalized medicine, and medical devices for the healthcare community, helping to save lives. QuickSTAT manages clinical trial logistics, transporting investigational drugs, clinical research specimens and biologics throughout the world, helping to bring new drugs to market… Read more here.
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity.
Vineti combines industry-leading software expertise with deep first-hand, knowledge of commercializing personalized cell therapies to digitize the supply chain, manufacturing and compliance systems for the delivery of transformational medicines. Vineti’s user-centric design creates a platform that is easier for physicians, nurses, and manufacturing operations to use, resulting in a superior user experience and reduced risk. The Vineti platform provides actionable insights to continually optimize the process, accelerating time to revenue and decreasing costs.
Blood Centers of America (BCA) is a national network of over 50 independent blood centers with just over 600 fixed collection and testing sites positioned throughout the country. BCA and its members provide a variety of human blood products, cells and tissues to the therapeutic, diagnostic and cell therapy industries. Whether you are sourcing research or clinical grade materials; blood or tissue derived products, or custom collections and/or collection services, BCA has a solution for you. Read more here.
Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine and advance cell therapy companies, organizations and institutions. Cognate provides specialized custom services to companies across all points of clinical and commercial development ranging from early preclinical studies, to mid phase trials and product scale-up though later stage clinical trials and commercial manufacturing.
As a not-for-profit research and development company, Draper focuses on the design, development and deployment of advanced technological solutions for the world’s most challenging and important problems. Draper’s Biomedical Solutions encompass organ-on-chip systems, cell therapy bioprocessing devices, rapid diagnostics, and neurotechnology.
Fresenius Kabi is a leading global health care company that focuses on pharmaceuticals and medical devices used to care for critically and chronically ill patients. Through our recent acquisition of Fenwal, we bring over 60 years experience advancing the fields of cell collection and separation with a deep expertise in closed-system processing. We recently launched Lovo, the only cell processing system that washes and concentrates white blood cells using filtration technology, specifically to serve the needs of the cellular therapies community.